site logo

iRhythm's future hazy after Medicare pricing saga erases 12-month high

Wall Street analysts project the cardiac wearables maker to lose tens of millions of dollars in revenue in coming years, leaving questions about the future of the once-hyped market leader.

Permission granted by iRhythm